Skip to content
OpenCapital
Get started

Theravance Biopharma TBPH Enterprise value

Enterprise value at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$452.74M+5.3%
LQD
Liquidia CorporationLQDA
$3.11B+184%
Royalty Pharma logo
Royalty PharmaRPRX
$28.94B+44.6%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$2.01B+78.3%
Precigen logo
PrecigenPGEN
$1.46B+234%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.83B-51.1%

Other financials

Income statement

See full
Revenue$17.7M+15.0%
Operating income-$9.5M+34.3%
Net income-$4.9M+63.7%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$288.1M+160%
Total debt$40.5M-15.9%
Total equity$290.6M+75.1%
Total assets$472.3M+37.5%

Cash flow

See full
Operating cash flow$73.3M+70.3%
CapEx$8.0K-95.8%
Free cash flow$59.6M+5,560%

Valuation

See full
Market cap$890.32M+67.5%
P/E7.8×—
P/S8.1×0.0×

Profitability

See full
Gross margin60.8%—
Operating margin1.2%+0.6pp
Net margin104.3%+71.4pp
FCF margin221.9%+206pp

Returns & leverage

See full
Return on equity50.2%+36.2pp
Debt / equity0.1×-0.2×
Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

$835.7Mmarket cap+$40.5Mtotal debt−$288.1Mcash and equivalents=$588.13M

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Theravance Biopharma's enterprise value?
Theravance Biopharma (TBPH) reported enterprise value of $588.13M in Q1 2026.
How has Theravance Biopharma's enterprise value changed year-over-year?
Theravance Biopharma's enterprise value increased by 55.1% year-over-year, from $379.31M to $588.13M.
What is the long-term trend for Theravance Biopharma's enterprise value?
Over 5 years (2020 to 2025), Theravance Biopharma's enterprise value has grown at a -6.0% compound annual growth rate (CAGR), from $1.12B to $822.98M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.